CSRxP Poll: Voters Overwhelmingly Reject Big Pharma’s Bogus Blame Game, Support Market-Based Solutions to Lower Rx Prices by Holding Big Pharma Accountable

Americans from Across the Political Spectrum Want Congress to Pass Bipartisan Legislation to Crack Down on Big Pharma’s Abuse of the Patent System and Boost List Price Transparency

Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released the results of a national survey today. The bipartisan survey was jointly conducted by two industry leading pollsters, Republican Erik Iverson of Moore Information Group (MIG), and Democrat Celinda Lake of Lake Research Partners (LRP).

“Big Pharma’s egregious anti-competitive practices and price-gouging have caused one-in-three voters in the United States to personally experience financial difficulty affording prescription drugs in the last year,” said CSRxP executive director Lauren Aronson. “Despite the pharmaceutical industry spending millions of dollars on a bogus blame game, Americans overwhelmingly identify Big Pharma as the culprit for out-of-control prescription drug prices and want lawmakers focused on holding brand name drug companies accountable.”

“Voters from across the political spectrum support bipartisan, market-based solutions to lower prescription drug prices by boosting competition from more affordable alternatives and increasing transparency to shine a light on the worst Big Pharma offenders,” Aronson continued. “Headed into the 2024 election cycle, lawmakers would be especially wise to recognize that more than four-in-five voters say they are more likely to back a candidate for Congress if they support the Cornyn-Blumenthal bill to help crack down on Big Pharma’s abuse of the patent system.”

The survey of 900 registered voters was commissioned by CSRxP and conducted by MIG and LRP from July 22-27, 2023. A memo from the pollsters on the results of the survey can be found HERE.

Key takeaways include:

Prescription Drug Prices and Big Pharma’s Egregious Anti-Competitive Tactics Are a Top Concern for U.S. Voters

Americans Rightly Identify Big Pharma as the Culprit for Rising Prescription Drug Prices and Reject The Pharmaceutical Industry’s Bogus Blame Game

Voters Overwhelming Support Market-Based Solutions to Hold Big Pharma Accountable and Lower Prescription Drug Prices by Boosting Competition and Increasing List Price Transparency

Read the memo from the pollsters on the results of the survey HERE.

Read more on solutions to crack down on Big Pharma’s egregious anti-competitive tactics and The Affordable Prescriptions for Patients Act (Cornyn-Blumenthal) HERE.

Learn more about solutions to increase list price transparency and The Fair Drug Pricing Act HERE.

Read more on market-based solutions to lower drug prices and hold Big Pharma accountable HERE.

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.